IP Library Granted Patent US 11,198,910
Granted Patent B2
US 11,198,910 · App. 16/327,698 · Granted Dec 14, 2021

Analysis of chromatin using a nicking enzyme

Inventors: Chaithanya Ponnaluri (Ipswich, MA); Hang-Gyeong Chin (Ipswich, MA); Pierre O. Esteve (Ipswich, MA); Sriharsa Pradhan (Ipswich, MA)
Assignee: New England Biolabs, Inc.
C12Q1/6886C12Q1/6806C12Q1/6827C12Q1/6841C12Q1/6869C12Q2521/301C12Q2521/331C12Q2525/117C12Q2527/156C12Q2531/119C12Q2535/122C12Q2543/10C12Q2563/131C12Q2565/133C12Q2600/154
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,198,910
App. No.
16/327,698
Granted
Dec 14, 2021
Kind
B2
Abstract

Provided herein, among other things, are various compositions and methods for analyzing chromatin. In some embodiments, the composition may comprise a mixture of a nicking enzyme, four dNTPs, at least one labeled dNTP and, optionally, a polymerase. In some embodiments, this method may comprise: obtaining a sample comprising chromatin, reacting the sample with the composition to selectively label the open chromatin in the sample, and analyzing the labeled sample.

Claims (19)

1. A method for analyzing open chromatin, comprising:

(a) obtaining a sample containing permeabilized cell nuclei, wherein the cell nuclei comprise chromatin;

(b) reacting the cell nuclei with a composition comprising a mixture of a nicking enzyme, four dNTPs, and at least one labeled dNTP, and a polymerase, to selectively label the chromatin; and

(c) analyzing the labeled nuclei of (b) for open chromatin, wherein the analyzing is done by:

(i) detecting an optically-detectable signal in the cell nuclei, if the at least one labeled dNTP comprises an optically detectable label; or

(ii) enriching for and then sequencing labeled DNA fragments that comprise the labeled nucleotide, if the labeled nucleotide comprises an affinity tag.

2. The method of claim 1 , wherein the at least one labeled dNTP comprises an optically detectable label and the analyzing step of (c) is performed by microscopy to produce an image of at least part of the sample.

3. The method of claim 1 , wherein the at least one labeled dNTP comprises an affinity tag and the analyzing step of (c) is performed by:

(i) fragmenting the DNA in the sample;

(ii) enriching for fragments that contain the labeled nucleotide; and

(iii) sequencing the enriched fragments.

4. The method of claim 1 , wherein the sample comprises isolated nuclei.

5. The method of claim 1 , wherein the sample comprises permeabilized cells, wherein the permeabilized cell nuclei are contained in the permeabilized cells.

6. The method of claim 5 , wherein the cells are fixed or unfixed.

7. The method of claim 1 , wherein the sample is a clinical sample.

8. The method of claim 7 , wherein the clinical sample is a tumor biopsy.

9. The method of claim 1 , wherein the nicking enzyme is methylation dependent and further comprises labeling of closed chromatin.

10. The method of claim 1 , wherein the nicking enzyme nicks at methylated CpGs.

11. The method of claim 1 , wherein the nicking enzyme is methylation insensitive, and the method further comprises labeling of open chromatin.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2019
From: PONNALURI, CHAITHANYA; CHIN, HANG-GYEONG; ESTEVE, PIERRE OLIVER; PRADHAN, SRIHARSA
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 048644/0902 →